Preventing Preeclampsia
- 21 October 1993
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 329 (17) , 1265-1266
- https://doi.org/10.1056/nejm199310213291711
Abstract
The report in this issue of the Journal by Sibai and colleagues1 highlights the search for a treatment to alter the incidence of preeclampsia. Hypertensive disorders complicate 10 to 12 percent of the 3.5 million pregnancies each year in the United States. The majority of the women with such disorders have preeclampsia (defined as hypertension and proteinuria beginning after 20 weeks of gestation), making preeclampsia the most common medical disease in pregnancy1. Although 85 percent of women with preeclampsia are nulliparous, multiparous women who have chronic hypertension antedating pregnancy have a 25 percent risk of superimposed preeclampsia. In developed . . .Keywords
This publication has 9 references indexed in Scilit:
- Prevention of Preeclampsia with Low-Dose Aspirin in Healthy, Nulliparous Pregnant WomenNew England Journal of Medicine, 1993
- Whole blood platelet aggregation in moderate and severe pre‐eclampsiaBJOG: An International Journal of Obstetrics and Gynaecology, 1993
- Low-dose aspirin therapy to prevent preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1993
- New Concepts in the Understanding of Hypertensive Diseases During PregnancyClinics in Perinatology, 1991
- Preeclampsia: An endothelial cell disorderAmerican Journal of Obstetrics and Gynecology, 1989
- The placental bed biopsy: Review from three European centersAmerican Journal of Obstetrics and Gynecology, 1986
- LOW-DOSE ASPIRIN PREVENTS PREGNANCY-INDUCED HYPERTENSION AND PRE-ECLAMPSIA IN ANGIOTENSIN-SENSITIVE PRIMIGRAVIDAEThe Lancet, 1986
- PREVENTION OF PRE-ECLAMPSIA BY EARLY ANTIPLATELET THERAPYThe Lancet, 1985
- Problems encountered in the treatment of pregnancy-induced hypertensionAmerican Journal of Obstetrics and Gynecology, 1978